HTTP 200 OK
Allow: GET, HEAD, OPTIONS
Content-Type: application/json
Vary: Accept
{
"id": 216,
"files": [],
"main_image": null,
"latitude": "52.36853",
"longitude": "4.88128",
"events": [
{
"id": 279,
"main_image": null,
"url": "https://research.annefrank.org/en/gebeurtenissen/d86fae9b-9972-47e4-a2d0-09c32813e274/",
"subjects": [
"https://research.annefrank.org/en/api/subjects/60372a46-0754-4cde-8460-8c2a436b879d?format=api",
"https://research.annefrank.org/en/api/subjects/f8e8c36c-5f55-43c9-910a-d68eb6a1077f?format=api"
],
"persons": [
"https://research.annefrank.org/en/api/persons/55a83554-90c5-4ef7-9df4-132c1af25453?format=api",
"https://research.annefrank.org/en/api/persons/b6db1cbb-c3f9-46e8-a36d-5bf6dd27fecf?format=api",
"https://research.annefrank.org/en/api/persons/4a16da66-e209-440c-9ca7-4ac535552649?format=api",
"https://research.annefrank.org/en/api/persons/28ca0b7b-d6a8-44c6-a54a-657863742d8f?format=api"
],
"location": "https://research.annefrank.org/en/api/locations/caa75771-165a-46ed-a848-c3a9df9eb52c?format=api",
"published": true,
"uuid": "d86fae9b-9972-47e4-a2d0-09c32813e274",
"name": "Formation of N.V. Sangostop",
"name_nl": "Oprichting van N.V. Sangostop",
"name_en": "Formation of N.V. Sangostop",
"content": "<p>The objective of the company founded by Benno Brahn was "the manufacture of haemostatic agents and other chemical and pharmaceutical articles, the trade in those agents and articles, and in their raw materials."<sup data-footnote-id=\"ya5u7\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup> Sangostop was affiliated with Brocades & Stheeman and with Thelopharm. Sangostop's records show several transactions with Opekta. Opekta's competitors Nederlandsche Pectine Industrie and Pomosin Import were also among its customers. </p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"ya5u7\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite>Nationaal Archief, Den Haag, Kamer van Koophandel Delft, Handelsregister 1921 – 1995 (toegang 3.17.19), inv. nr. 508, dossier 16118.</cite></li>\r\n</ol>\r\n</section>",
"content_nl": "<p>Doelstelling van het bedrijf door Benno Brahn opgerichte bedrijf was '<em>het fabriceren van bloedstelpende middelen en andere chemische en farmaceutische artikelen, de handel in die middelen en artikelen en in de grondstoffen daarvan</em>.'<sup data-footnote-id=\"ya5u7\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup> Sangostop was gelieerd aan Brocades & Stheeman en aan Thelopharm. Uit de boekhouding van Sangostop blijken diverse transacties met Opekta. Ook Opekta-concurrent Nederlandsche Pectine Industrie en Pomosin Import behoorden tot de afnemers. </p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"ya5u7\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite>Nationaal Archief, Den Haag, Kamer van Koophandel Delft, Handelsregister 1921 – 1995 (toegang 3.17.19), inv. nr. 508, dossier 16118.</cite></li>\r\n</ol>\r\n</section>",
"content_en": "<p>The objective of the company founded by Benno Brahn was "the manufacture of haemostatic agents and other chemical and pharmaceutical articles, the trade in those agents and articles, and in their raw materials."<sup data-footnote-id=\"ya5u7\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup> Sangostop was affiliated with Brocades & Stheeman and with Thelopharm. Sangostop's records show several transactions with Opekta. Opekta's competitors Nederlandsche Pectine Industrie and Pomosin Import were also among its customers. </p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"ya5u7\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite>Nationaal Archief, Den Haag, Kamer van Koophandel Delft, Handelsregister 1921 – 1995 (toegang 3.17.19), inv. nr. 508, dossier 16118.</cite></li>\r\n</ol>\r\n</section>",
"date": "1934-03-10",
"date_start": null,
"date_end": null,
"summary": "Sangostop was a pharmaceutical company with which Opekta did business.",
"summary_nl": "Sangostop was een farmaceutisch bedrijf waarmee Opekta zaken deed.\r\n\r\n\r\n\r\n\r\n",
"summary_en": "Sangostop was a pharmaceutical company with which Opekta did business.",
"same_as": null,
"files": []
}
],
"subjects": [
{
"id": 396124419,
"image": null,
"url": "https://research.annefrank.org/en/onderwerpen/f10c5572-ef2e-4ba0-995d-57828a30f7bd/",
"published": true,
"uuid": "f10c5572-ef2e-4ba0-995d-57828a30f7bd",
"name": "Businesses",
"name_nl": "Bedrijven",
"name_en": "Businesses",
"description": "<p>The objective of businesses is to sell products and/or services to customers, thereby generating revenue.</p>",
"description_nl": "<p>Bedrijven hebben tot doel producten en/of diensten te verkopen aan klanten, waardoor omzet kan worden gedraaid.</p>",
"description_en": "<p>The objective of businesses is to sell products and/or services to customers, thereby generating revenue.</p>",
"summary": "Businesses aim to sell products and/or services to customers, thereby generating revenue.",
"summary_nl": "Bedrijven hebben tot doel producten en/of diensten te verkopen aan klanten, waardoor omzet kan worden gedraaid.",
"summary_en": "Businesses aim to sell products and/or services to customers, thereby generating revenue.",
"same_as": [
"https://data.niod.nl/WO2_Thesaurus/2210"
],
"parent": null,
"files": []
}
],
"related_locations": [
"https://research.annefrank.org/en/api/locations/04bc398b-9132-421d-be07-26d89aecf727?format=api",
"https://research.annefrank.org/en/api/locations/e81eeb71-37e6-4299-9a32-d4d419af2117?format=api",
"https://research.annefrank.org/en/api/locations/84898f4e-5c32-47d1-bff4-d377c343c5b2?format=api",
"https://research.annefrank.org/en/api/locations/5e6e4c0b-e255-4b81-9abc-a8b22fd9d87c?format=api",
"https://research.annefrank.org/en/api/locations/17e62508-f7db-41ee-bf60-e7f87d4dd63c?format=api",
"https://research.annefrank.org/en/api/locations/2aaa7b1a-46b7-49f3-9908-dd3a35052bd6?format=api",
"https://research.annefrank.org/en/api/locations/fca17b8f-5066-4200-a73e-76bccc6ef720?format=api",
"https://research.annefrank.org/en/api/locations/1a319571-a93e-4566-9396-a4d6e61833ed?format=api",
"https://research.annefrank.org/en/api/locations/41740528-a1d2-4a88-8b7c-c78e01a8ee6d?format=api",
"https://research.annefrank.org/en/api/locations/aedb3425-3b2c-4479-9d12-9ff63918c0b7?format=api",
"https://research.annefrank.org/en/api/locations/ea19e0cf-5fd7-4bb6-9dd9-63c328018639?format=api",
"https://research.annefrank.org/en/api/locations/4caabcc8-204b-438d-915c-1e6ea54630bb?format=api",
"https://research.annefrank.org/en/api/locations/83d54925-63d3-43a3-9f96-a9535224eb3d?format=api",
"https://research.annefrank.org/en/api/locations/6ef7b88e-bdae-4edb-8265-23201452f19b?format=api",
"https://research.annefrank.org/en/api/locations/0f90d12e-14ef-4acb-b44f-c3692319565a?format=api",
"https://research.annefrank.org/en/api/locations/0f5b8243-d6ba-4498-b411-126dfe806d85?format=api",
"https://research.annefrank.org/en/api/locations/0cfff667-b7b7-42e2-b01b-848d60758275?format=api",
"https://research.annefrank.org/en/api/locations/18a78a8e-12a1-4e8c-b38f-20ab70ff1da5?format=api",
"https://research.annefrank.org/en/api/locations/f2e450aa-840f-4dd8-84cf-548ce515e6d0?format=api",
"https://research.annefrank.org/en/api/locations/efee09b0-5605-4f5b-894c-91a96938e30d?format=api",
"https://research.annefrank.org/en/api/locations/2ce70ffc-474f-4743-a9a8-dd4ed4e59c77?format=api",
"https://research.annefrank.org/en/api/locations/56d301cf-e04e-47fd-884b-6685a83f00b9?format=api",
"https://research.annefrank.org/en/api/locations/fa46b11f-7c2b-4fbc-ac9b-82fb58e805a6?format=api",
"https://research.annefrank.org/en/api/locations/aeeb3d86-ddec-4d5d-a51a-5a0749bc3972?format=api",
"https://research.annefrank.org/en/api/locations/22e16ce9-e2a5-476f-b517-7e48026e719e?format=api",
"https://research.annefrank.org/en/api/locations/f9bad9c3-50bb-41b5-b528-74c36e40d028?format=api",
"https://research.annefrank.org/en/api/locations/6b0dbaa0-4815-4f3e-ab1c-e0ee6196188e?format=api",
"https://research.annefrank.org/en/api/locations/c885285f-6d92-48fc-817f-543f6f20f9bf?format=api",
"https://research.annefrank.org/en/api/locations/c590cc2d-a203-4b6b-b2bb-6db6e47a523c?format=api",
"https://research.annefrank.org/en/api/locations/5c893854-c6f4-4ec1-8bc7-3f53d91174cc?format=api",
"https://research.annefrank.org/en/api/locations/45c5caab-86df-4b28-91ba-f2d9fd02d20e?format=api",
"https://research.annefrank.org/en/api/locations/ce8468a7-c299-43c3-a730-4b3009a56059?format=api",
"https://research.annefrank.org/en/api/locations/a4257fc0-726f-49b3-9912-80a4aacbacbb?format=api",
"https://research.annefrank.org/en/api/locations/a7bc55a0-7741-4259-a387-42959e20d899?format=api",
"https://research.annefrank.org/en/api/locations/ceacea5d-5d1a-4618-9cdc-de7c26765040?format=api",
"https://research.annefrank.org/en/api/locations/f0eef6aa-3307-4bab-899c-0d69504e3eb0?format=api",
"https://research.annefrank.org/en/api/locations/6e696049-a72e-459b-beba-e66fc4cbf66f?format=api"
],
"url": "https://research.annefrank.org/en/locaties/caa75771-165a-46ed-a848-c3a9df9eb52c/",
"published": true,
"name": "Thelopharm, N.V.",
"name_nl": "Thelopharm, N.V.",
"name_en": "Thelopharm, N.V.",
"uuid": "caa75771-165a-46ed-a848-c3a9df9eb52c",
"content": "<p><strong>Addresss</strong>: Looiersgracht 25, Amsterdam.<sup data-footnote-id=\"0grke\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup></p>\r\n\r\n<p>Thelopharm was a pharmaceutical company affiliated with Sangostop<sup data-footnote-id=\"snsll\"><a href=\"#footnote-2\" id=\"footnote-marker-2-1\" rel=\"footnote\">[2]</a></sup> and the brothers Max and Benno Brahn.<sup data-footnote-id=\"3z0yq\"><a href=\"#footnote-3\" id=\"footnote-marker-3-1\" rel=\"footnote\">[3]</a></sup> Max Brahn was director of Thelopharm.<sup data-footnote-id=\"40kqs\"><a href=\"#footnote-4\" id=\"footnote-marker-4-1\" rel=\"footnote\">[4]</a></sup> On <strong>20 March 1936</strong>, an annual meeting took place in the building of the Hollandsche Bank Unie, immediately following that of Sangostop.<sup data-footnote-id=\"4hlrf\"><a href=\"#footnote-5\" id=\"footnote-marker-5-1\" rel=\"footnote\">[5]</a></sup></p>\r\n\r\n<p>The company was also affiliated with Brocades Stheeman. It engaged in the manufacturing and trading of pharmaceutical and chemical products. Max Brahn became a commissioner and vice-chairman of the Supervisory Board of Thelopharm in <strong>November 1939</strong>.<sup data-footnote-id=\"d96vo\"><a href=\"#footnote-6\" id=\"footnote-marker-6-1\" rel=\"footnote\">[6]</a></sup></p>\r\n\r\n<p>In <strong>1943</strong> the registered capital amounted to one hundred thousand guilders, of which twenty-four thousand had been issued.<sup data-footnote-id=\"ic3jl\"><a href=\"#footnote-7\" id=\"footnote-marker-7-1\" rel=\"footnote\">[7]</a></sup> In <strong>1945</strong>, Thelopharm owned a Canadian patent on an insulin application invented by Benno Brahn.<sup data-footnote-id=\"f92k1\"><a href=\"#footnote-8\" id=\"footnote-marker-8-1\" rel=\"footnote\">[8]</a></sup></p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"0grke\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite><em>Naamlijst voor den interlocalen telefoondienst</em>, z.p.: Hoofdbestuur der P.T.T., januari 1941, p. 271.</cite></li>\r\n\t<li data-footnote-id=\"snsll\" id=\"footnote-2\"><sup><a href=\"#footnote-marker-2-1\">^</a> </sup><cite>Sangostop was een farmaceutisch bedrijf waarmee Opekta zaken deed.</cite></li>\r\n\t<li data-footnote-id=\"3z0yq\" id=\"footnote-3\"><sup><a href=\"#footnote-marker-3-1\">^</a> </sup><cite>Zakenrelatie van Otto Frank. Otto Frank heeft Brahns telefoonnummer in zijn agenda's genoteerd van <strong>1937</strong> en <strong>1946</strong> t/m <strong>1952</strong>. Anne Frank Stichting, Anne Frank Collectie, Otto Frank Archief, reg. codes OFA_001 en 003 t/m 009.</cite></li>\r\n\t<li data-footnote-id=\"40kqs\" id=\"footnote-4\"><sup><a href=\"#footnote-marker-4-1\">^</a> </sup><cite>Stadsarchief Amsterdam, Dienst Bevolkingsregister, Archiefkaarten (toegangsnummer 30238): Archiefkaart M. Brahn.</cite></li>\r\n\t<li data-footnote-id=\"4hlrf\" id=\"footnote-5\"><sup><a href=\"#footnote-marker-5-1\">^</a> </sup><cite>“Vergaderingen”, <em>Algemeen Handelsblad</em>, 20 maart 1936 (ochtendeditie).</cite></li>\r\n\t<li data-footnote-id=\"d96vo\" id=\"footnote-6\"><sup><a href=\"#footnote-marker-6-1\">^</a> </sup><cite>N.E. Onnes Rost wordt voorzitter. “Handelsregister. Wijzigingen November 1939”, <em>Pharmaceutisch Weekblad</em>.<em> Orgaan van de Nederlandsche Maatschappij ter bevordering van de Pharmacie</em>, 6 januari 1940.</cite></li>\r\n\t<li data-footnote-id=\"ic3jl\" id=\"footnote-7\"><sup><a href=\"#footnote-marker-7-1\">^</a> </sup><cite><em>Deutsche Zeitung in den Niederlanden</em>, 19 oktober 1943, p. 6.</cite></li>\r\n\t<li data-footnote-id=\"f92k1\" id=\"footnote-8\"><sup><a href=\"#footnote-marker-8-1\">^</a> </sup><cite>Canadian Intellectual Property Office, <a href=\"http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html\" target=\"_blank\">http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html</a> (geraadpleegd 14 juli 2017).</cite></li>\r\n</ol>\r\n</section>",
"content_nl": "<p><strong>Adres</strong>: Looiersgracht 25, Amsterdam.<sup data-footnote-id=\"0grke\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup></p>\r\n\r\n<p>Thelopharm was een farmaceutisch bedrijf gelieerd aan Sangostop<sup data-footnote-id=\"snsll\"><a href=\"#footnote-2\" id=\"footnote-marker-2-1\" rel=\"footnote\">[2]</a></sup> en aan de broers Max en Benno Brahn.<sup data-footnote-id=\"3z0yq\"><a href=\"#footnote-3\" id=\"footnote-marker-3-1\" rel=\"footnote\">[3]</a></sup> Max Brahn was directeur van Thelopharm.<sup data-footnote-id=\"40kqs\"><a href=\"#footnote-4\" id=\"footnote-marker-4-1\" rel=\"footnote\">[4]</a></sup> Op <strong>20 maart 1936 </strong>vond er een jaarvergadering plaats in het gebouw van de Hollandsche Bank Unie, direct volgend op die van Sangostop.<sup data-footnote-id=\"4hlrf\"><a href=\"#footnote-5\" id=\"footnote-marker-5-1\" rel=\"footnote\">[5]</a></sup></p>\r\n\r\n<p>De firma was ook gelieerd aan Brocades Stheeman. Ze deed de vervaardiging van en handel in farmaceutische en chemische producten. Max Brahn werd in <strong>november</strong> <strong>1939 </strong>commissaris en vicevoorzitter van de Raad van Commissarissen van Thelopharm.<sup data-footnote-id=\"d96vo\"><a href=\"#footnote-6\" id=\"footnote-marker-6-1\" rel=\"footnote\">[6]</a></sup></p>\r\n\r\n<p>In <strong>1943 </strong>bedroeg het maatschappelijk kapitaal honderdduizend gulden, waarvan vierentwintigduizend geplaatst was.<sup data-footnote-id=\"ic3jl\"><a href=\"#footnote-7\" id=\"footnote-marker-7-1\" rel=\"footnote\">[7]</a></sup> Thelopharm was in <strong>1945 </strong>eigenaar van een Canadees patent op een door Benno Brahn uitgevonden insulinetoepassing.<sup data-footnote-id=\"f92k1\"><a href=\"#footnote-8\" id=\"footnote-marker-8-1\" rel=\"footnote\">[8]</a></sup></p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"0grke\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite><em>Naamlijst voor den interlocalen telefoondienst</em>, z.p.: Hoofdbestuur der P.T.T., januari 1941, p. 271.</cite></li>\r\n\t<li data-footnote-id=\"snsll\" id=\"footnote-2\"><sup><a href=\"#footnote-marker-2-1\">^</a> </sup><cite>Sangostop was een farmaceutisch bedrijf waarmee Opekta zaken deed.</cite></li>\r\n\t<li data-footnote-id=\"3z0yq\" id=\"footnote-3\"><sup><a href=\"#footnote-marker-3-1\">^</a> </sup><cite>Zakenrelatie van Otto Frank. Otto Frank heeft Brahns telefoonnummer in zijn agenda's genoteerd van <strong>1937</strong> en <strong>1946</strong> t/m <strong>1952</strong>. Anne Frank Stichting, Anne Frank Collectie, Otto Frank Archief, reg. codes OFA_001 en 003 t/m 009.</cite></li>\r\n\t<li data-footnote-id=\"40kqs\" id=\"footnote-4\"><sup><a href=\"#footnote-marker-4-1\">^</a> </sup><cite>Stadsarchief Amsterdam, Dienst Bevolkingsregister, Archiefkaarten (toegangsnummer 30238): Archiefkaart M. Brahn.</cite></li>\r\n\t<li data-footnote-id=\"4hlrf\" id=\"footnote-5\"><sup><a href=\"#footnote-marker-5-1\">^</a> </sup><cite>“Vergaderingen”, <em>Algemeen Handelsblad</em>, 20 maart 1936 (ochtendeditie).</cite></li>\r\n\t<li data-footnote-id=\"d96vo\" id=\"footnote-6\"><sup><a href=\"#footnote-marker-6-1\">^</a> </sup><cite>N.E. Onnes Rost wordt voorzitter. “Handelsregister. Wijzigingen November 1939”, <em>Pharmaceutisch Weekblad</em>.<em> Orgaan van de Nederlandsche Maatschappij ter bevordering van de Pharmacie</em>, 6 januari 1940.</cite></li>\r\n\t<li data-footnote-id=\"ic3jl\" id=\"footnote-7\"><sup><a href=\"#footnote-marker-7-1\">^</a> </sup><cite><em>Deutsche Zeitung in den Niederlanden</em>, 19 oktober 1943, p. 6.</cite></li>\r\n\t<li data-footnote-id=\"f92k1\" id=\"footnote-8\"><sup><a href=\"#footnote-marker-8-1\">^</a> </sup><cite>Canadian Intellectual Property Office,<a href=\"http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html\" target=\"_blank\">http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html</a> (geraadpleegd 14 juli 2017).</cite></li>\r\n</ol>\r\n</section>",
"content_en": "<p><strong>Addresss</strong>: Looiersgracht 25, Amsterdam.<sup data-footnote-id=\"0grke\"><a href=\"#footnote-1\" id=\"footnote-marker-1-1\" rel=\"footnote\">[1]</a></sup></p>\r\n\r\n<p>Thelopharm was a pharmaceutical company affiliated with Sangostop<sup data-footnote-id=\"snsll\"><a href=\"#footnote-2\" id=\"footnote-marker-2-1\" rel=\"footnote\">[2]</a></sup> and the brothers Max and Benno Brahn.<sup data-footnote-id=\"3z0yq\"><a href=\"#footnote-3\" id=\"footnote-marker-3-1\" rel=\"footnote\">[3]</a></sup> Max Brahn was director of Thelopharm.<sup data-footnote-id=\"40kqs\"><a href=\"#footnote-4\" id=\"footnote-marker-4-1\" rel=\"footnote\">[4]</a></sup> On <strong>20 March 1936</strong>, an annual meeting took place in the building of the Hollandsche Bank Unie, immediately following that of Sangostop.<sup data-footnote-id=\"4hlrf\"><a href=\"#footnote-5\" id=\"footnote-marker-5-1\" rel=\"footnote\">[5]</a></sup></p>\r\n\r\n<p>The company was also affiliated with Brocades Stheeman. It engaged in the manufacturing and trading of pharmaceutical and chemical products. Max Brahn became a commissioner and vice-chairman of the Supervisory Board of Thelopharm in <strong>November 1939</strong>.<sup data-footnote-id=\"d96vo\"><a href=\"#footnote-6\" id=\"footnote-marker-6-1\" rel=\"footnote\">[6]</a></sup></p>\r\n\r\n<p>In <strong>1943</strong> the registered capital amounted to one hundred thousand guilders, of which twenty-four thousand had been issued.<sup data-footnote-id=\"ic3jl\"><a href=\"#footnote-7\" id=\"footnote-marker-7-1\" rel=\"footnote\">[7]</a></sup> In <strong>1945</strong>, Thelopharm owned a Canadian patent on an insulin application invented by Benno Brahn.<sup data-footnote-id=\"f92k1\"><a href=\"#footnote-8\" id=\"footnote-marker-8-1\" rel=\"footnote\">[8]</a></sup></p>\r\n\r\n<section class=\"footnotes\">\r\n<header>\r\n<h2>Footnotes</h2>\r\n</header>\r\n\r\n<ol>\r\n\t<li data-footnote-id=\"0grke\" id=\"footnote-1\"><sup><a href=\"#footnote-marker-1-1\">^</a> </sup><cite><em>Naamlijst voor den interlocalen telefoondienst</em>, z.p.: Hoofdbestuur der P.T.T., januari 1941, p. 271.</cite></li>\r\n\t<li data-footnote-id=\"snsll\" id=\"footnote-2\"><sup><a href=\"#footnote-marker-2-1\">^</a> </sup><cite>Sangostop was een farmaceutisch bedrijf waarmee Opekta zaken deed.</cite></li>\r\n\t<li data-footnote-id=\"3z0yq\" id=\"footnote-3\"><sup><a href=\"#footnote-marker-3-1\">^</a> </sup><cite>Zakenrelatie van Otto Frank. Otto Frank heeft Brahns telefoonnummer in zijn agenda's genoteerd van <strong>1937</strong> en <strong>1946</strong> t/m <strong>1952</strong>. Anne Frank Stichting, Anne Frank Collectie, Otto Frank Archief, reg. codes OFA_001 en 003 t/m 009.</cite></li>\r\n\t<li data-footnote-id=\"40kqs\" id=\"footnote-4\"><sup><a href=\"#footnote-marker-4-1\">^</a> </sup><cite>Stadsarchief Amsterdam, Dienst Bevolkingsregister, Archiefkaarten (toegangsnummer 30238): Archiefkaart M. Brahn.</cite></li>\r\n\t<li data-footnote-id=\"4hlrf\" id=\"footnote-5\"><sup><a href=\"#footnote-marker-5-1\">^</a> </sup><cite>“Vergaderingen”, <em>Algemeen Handelsblad</em>, 20 maart 1936 (ochtendeditie).</cite></li>\r\n\t<li data-footnote-id=\"d96vo\" id=\"footnote-6\"><sup><a href=\"#footnote-marker-6-1\">^</a> </sup><cite>N.E. Onnes Rost wordt voorzitter. “Handelsregister. Wijzigingen November 1939”, <em>Pharmaceutisch Weekblad</em>.<em> Orgaan van de Nederlandsche Maatschappij ter bevordering van de Pharmacie</em>, 6 januari 1940.</cite></li>\r\n\t<li data-footnote-id=\"ic3jl\" id=\"footnote-7\"><sup><a href=\"#footnote-marker-7-1\">^</a> </sup><cite><em>Deutsche Zeitung in den Niederlanden</em>, 19 oktober 1943, p. 6.</cite></li>\r\n\t<li data-footnote-id=\"f92k1\" id=\"footnote-8\"><sup><a href=\"#footnote-marker-8-1\">^</a> </sup><cite>Canadian Intellectual Property Office, <a href=\"http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html\" target=\"_blank\">http://brevets-patents.ic.gc.ca/opic-cipo/cpd/eng/patent/425759/summary.html</a> (geraadpleegd 14 juli 2017).</cite></li>\r\n</ol>\r\n</section>",
"position": "SRID=4326;POINT (4.88128 52.36853)",
"summary": "Thelopharm was a pharmaceutical company affiliated with Sangostop. Opekta did business with Sangostop.",
"summary_nl": "Thelopharm was een farmaceutisch bedrijf gelieerd aan Sangostop. Opekta deed zaken met Sangostop.",
"summary_en": "Thelopharm was a pharmaceutical company affiliated with Sangostop. Opekta did business with Sangostop.",
"same_as": null,
"street": "",
"zipcode": "",
"city": "Amsterdam",
"state": "",
"land": "",
"location_events": [
279
]
}